HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease.

AuthorsR K Moitra, J M Ledingham, R G Hull, F C McCrae, A L Thomas, R Shaban, K R Mackay
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 44 Issue 2 Pg. 256-7 (Feb 2005) ISSN: 1462-0324 [Print] England
PMID15637036 (Publication Type: Letter)
Chemical References
  • Antirheumatic Agents
  • Methotrexate
Topics
  • Administration, Oral
  • Antirheumatic Agents (administration & dosage)
  • Drug Administration Schedule
  • Humans
  • Infusions, Parenteral
  • Methotrexate (administration & dosage)
  • Rheumatic Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: